Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome.
暂无分享,去创建一个
Anna Goldenberg | Lauren Erdman | Suzanne D Vernon | Patrick O. McGowan | A. Goldenberg | S. Vernon | P. McGowan | L. Erdman | Wilfred C de Vega | Patrick O McGowan | Wilfred C. de Vega
[1] James F. Jones,et al. An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome , 2009, BMC medicine.
[2] A. Baccarelli,et al. Storage conditions and stability of global DNA methylation in placental tissue. , 2013, Epigenomics.
[3] Patrick O. McGowan,et al. The epigenetic landscape of myalgic encephalomyelitis/chronic fatigue syndrome: deciphering complex phenotypes. , 2017, Epigenomics.
[4] M. Esteller,et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.
[5] Paul Kellam,et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. , 2008, The Journal of infectious diseases.
[6] A. Light,et al. Differences in Metabolite-Detecting, Adrenergic, and Immune Gene Expression After Moderate Exercise in Patients With Chronic Fatigue Syndrome, Patients With Multiple Sclerosis, and Healthy Controls , 2012, Psychosomatic medicine.
[7] N. Unterwalder,et al. Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome , 2014, PloS one.
[8] J. DeLuca,et al. Personality dimensions in the chronic fatigue syndrome: a comparison with multiple sclerosis and depression. , 1996, Journal of psychiatric research.
[9] A. Oshlack,et al. SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips , 2012, Genome Biology.
[10] E. Bullmore,et al. Hubs of brain functional networks are radically reorganized in comatose patients , 2012, Proceedings of the National Academy of Sciences.
[11] Devin C. Koestler,et al. DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.
[12] Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue , 2009, Population health metrics.
[13] R. Weksberg,et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray , 2013, Epigenetics.
[14] T. Spector,et al. Epigenetic differences arise during the lifetime of monozygotic twins. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Buchwald,et al. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. , 1994, Archives of internal medicine.
[16] A. Rademaker,et al. A community-based study of chronic fatigue syndrome. , 1999, Archives of internal medicine.
[17] The Emerging Role of Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/cfs) , 2014, Molecular Neurobiology.
[18] M. Szyf,et al. The effects of pH on DNA methylation state: In vitro and post-mortem brain studies , 2008, Journal of Neuroscience Methods.
[19] M. Lenzenweger. ENDOPHENOTYPE, INTERMEDIATE PHENOTYPE, BIOMARKER: DEFINITIONS, CONCEPT COMPARISONS, CLARIFICATIONS , 2013, Depression and anxiety.
[20] D. Staines,et al. A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis , 2014, Health and Quality of Life Outcomes.
[21] David C Hoaglin,et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. , 2003, Archives of internal medicine.
[22] S. Beck,et al. Analysis pipelines and packages for Infinium HumanMethylation450 BeadChip (450k) data , 2015, Methods.
[23] The validity of an empirical delineation of heterogeneity in chronic unexplained fatigue. , 2006, Pharmacogenomics.
[24] Paolo Vineis,et al. Performance in Omics Analyses of Blood Samples in Long-Term Storage: Opportunities for the Exploitation of Existing Biobanks in Environmental Health Research , 2013, Environmental health perspectives.
[25] Benjamin J. Raphael,et al. Network propagation: a universal amplifier of genetic associations , 2017, Nature Reviews Genetics.
[26] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[27] M. Maes. Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue, somatization and psychosomatic symptoms , 2009, Current opinion in psychiatry.
[28] James R. Brown,et al. No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank , 2014, BMC Research Notes.
[29] Jiuyong Li,et al. Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data , 2016, PloS one.
[30] Patrick O. McGowan,et al. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) , 2017, BMC Medical Genomics.
[31] Rafael A. Irizarry,et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..
[32] B. Ford,et al. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls , 2013, Clinical and experimental immunology.
[33] Gordon Broderick,et al. Gene Expression Correlates of Unexplained Fatigue , 2006, Pharmacogenomics.
[34] D. Bell,et al. Understanding long-term outcomes of chronic fatigue syndrome. , 2012, Journal of clinical psychology.
[35] L. Morales,et al. The RAND-36 measure of health-related quality of life , 2001, Annals of medicine.
[36] Beate Peter,et al. Motor sequencing deficit as an endophenotype of speech sound disorder: a genome-wide linkage analysis in a multigenerational family , 2012, Psychiatric genetics.
[37] A. House,et al. Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: a case–control study , 2003, Psychological Medicine.
[38] Ø. Fluge,et al. Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study , 2011, PloS one.
[39] Zhuowen Tu,et al. Similarity network fusion for aggregating data types on a genomic scale , 2014, Nature Methods.
[40] M. Meeus,et al. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome , 2006, Clinical Rheumatology.
[41] Suzanne D Vernon,et al. Cost Effectiveness and Resource Allocation Open Access the Economic Impact of Chronic Fatigue Syndrome , 2022 .
[42] J. Tost,et al. DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. , 2009, Methods in molecular biology.
[43] I. Mena,et al. Myalgic encephalomyelitis: International Consensus Criteria , 2011, Journal of internal medicine.
[44] Jin-Mann S. Lin,et al. The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs , 2011 .
[45] Nicholas G Martin,et al. Contribution of genetic variation to transgenerational inheritance of DNA methylation , 2014, Genome Biology.
[46] Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) , 2014, Journal of Clinical Pathology.
[47] Marianna Aprile,et al. RNA-Seq and human complex diseases: recent accomplishments and future perspectives , 2012, European Journal of Human Genetics.
[48] James F. Jones,et al. Psychiatric Comorbidity in Persons With Chronic Fatigue Syndrome Identified From the Georgia Population , 2009, Psychosomatic medicine.
[49] Kefeng Li,et al. Metabolic features of chronic fatigue syndrome , 2016, Proceedings of the National Academy of Sciences.
[50] M. Leandro,et al. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross‐sectional study , 2016, Clinical and experimental immunology.
[51] Dan Wang,et al. IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data , 2012, Bioinform..
[52] Eldon Emberly,et al. Factors underlying variable DNA methylation in a human community cohort , 2012, Proceedings of the National Academy of Sciences.
[53] U. Vollmer-Conna,et al. An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. , 2006, Pharmacogenomics.
[54] Tom R. Gaunt,et al. Systematic identification of genetic influences on methylation across the human life course , 2016, Genome Biology.
[55] A. Jablensky,et al. Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition , 2011, Molecular Psychiatry.
[56] Huiguang He,et al. Combining Disrupted and Discriminative Topological Properties of Functional Connectivity Networks as Neuroimaging Biomarkers for Accurate Diagnosis of Early Tourette Syndrome Children , 2018, Molecular Neurobiology.
[57] D. Papanicolaou,et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. , 2000, The Journal of clinical endocrinology and metabolism.
[58] A. M. Ramsay,et al. Myalgic encephalomyelitis--a persistent enteroviral infection? , 1990, Postgraduate medical journal.
[59] C. Gieger,et al. DNA methylation and body-mass index: a genome-wide analysis , 2014, The Lancet.
[60] C. Dancey,et al. Symptoms, impairment and illness intrusiveness–their relationship with depression in women with CFS/ME , 2008, Psychology & health.
[61] Luba Kalaydjieva,et al. Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit. , 2005, American journal of human genetics.
[62] J. Casanova,et al. IL‐12Rβ1 Deficiency: Mutation Update and Description of the IL12RB1 Variation Database , 2013, Human mutation.
[63] Junfeng Xia,et al. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach , 2015, Oncotarget.
[64] Patrick O. McGowan,et al. DNA Methylation Modifications Associated with Chronic Fatigue Syndrome , 2014, PloS one.
[65] Peter A. Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.
[66] B. Bradley,et al. DNA extracted from saliva for methylation studies of psychiatric traits: Evidence tissue specificity and relatedness to brain , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[67] Ichigaku Takigawa,et al. Annotating gene function by combining expression data with a modular gene network , 2007, ISMB/ECCB.
[68] Evan E. Eichler,et al. A Genotype-First Approach to Defining the Subtypes of a Complex Disease , 2014, Cell.
[69] A. Rademaker,et al. CFS prevalence and risk factors over time , 2011, Journal of health psychology.
[70] Ian Hickie,et al. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.
[71] S. Kiani-Alikhan,et al. Chronic fatigue syndrome, the immune system and viral infection , 2012, Brain, Behavior, and Immunity.
[72] D. Nutt,et al. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis , 2009, Journal of Clinical Pathology.